HOUSE 5958118th CongressReferred to the Subcommittee on Health.

Drug-price Transparency for Consumers Act of 2023

Last Action: 12/17/2024

Actions

2024-12-17Referred to the Subcommittee on Health.
2023-10-25Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2023-10-25Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2023-10-13Introduced in House
2023-10-13Introduced in House

Cosponsors (1)

Zachary Nunn (R-IA)

Subjects

Administrative law and regulatory procedures
Civil actions and liability
Department of Health and Human Services
Health care costs and insurance
Marketing and advertising
Prescription drugs

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.